Company: CDLX
Filing Date: 2025-04-03
Form Type: ARS
Source: 0001666071-25-000048
Chunk: 167

Company: Cardlytics, Inc.
Filing Date: 2025-04-03
Form: ARS
Chunk 167
---
 June 4, 2020, among Cardlytics, Inc. and JPMorgan Chase Bank, National Association 10-Q 001-38386 10.1 8/4/2020 10.11^ 2020 Amendment to General Services Agreement, dated December 2, 2020, by and between the Registrant and Bank of America, N.A. 10-K 001-38386 10.27 3/3/2021 10.12 Consent to Loan and Security Agreement, dated as of March 5, 2021, by and among Cardlytics, Inc., as Borrower, BSpears Merger Sub II, LLC, as additional borrower, and Pacific Western Bank, as Lender 10-Q 001-38386 10.1 5/4/2021 10.13^ Agreement and Plan of Merger, dated April 12, 2021, by and among Cardlytics, Inc., Bridg, Inc., Mr. T Merger Sub, Inc., and Shareholder Representative Services LLC 8-K 001-38386 10.1 11/18/2022 10.14^ General Service Agreement dated as of July 7, 2022 by and between the Registrant and Bank of America, N.A. 10-Q 001-38386 10.2 8/2/2022 10.15^ Statement of Work Agreement dated as of July 7, 2022 by and between the Registrant and Bank of America, N.A. 10-Q 001-38386 10.3 8/2/2022 10.16† Offer Letter Agreement between Karim Temsamani and Cardlytics, Inc. 10-Q 001-38386 10.2 11/1/2022 10.17† Severance Agreement between Karim Temsamani and Cardlytics, Inc. 10-Q 001-38386 10.3 11/1/2022 10.18† Severance Agreement between Nick Lynton and Cardlytics, Inc. 10-Q 001-38386 10.4 11/1/2022 10.19† 2022 Inducement Plan 10-Q 001-38386 10.7 11/1/2022 10.20† Form of option grant notice and agreement under 2022